BGNE - EU regulators approve BeiGene's tislelizumab for lung cancer
2024-04-23 12:15:00 ET
More on BeiGene
- BeiGene Still Bleeding Red Ink Despite Blockbuster Drug
- BeiGene: Debating On Finally Establishing A Position
- BeiGene gets FDA approval for esophageal cancer drug Tevimbra
- BeiGene gains as access to leukemia drug Brukinsa expands
- Seeking Alpha’s Quant Rating on BeiGene